The U.S. neurological device market was valued at over $7.6 billion in 2024 and is projected to grow at a CAGR of 3.8%, reaching nearly $10 billion by 2031.
Market growth is driven by:
- Advancements in neuromodulation, brain-computer interfaces (BCIs), and AI-powered diagnostics.
- Increasing demand for minimally invasive neurovascular interventions.
- Expanded indications for neuromodulation in pain management and movement disorders.
The 2025 report suite covers:
- Cerebrospinal Fluid (CSF) Management
- Detachable Coil & Liquid Embolic Devices
- Neurovascular Catheters, Guidewires, Stents & Thrombectomy Devices
- Neuromodulation Devices & Intrathecal Pumps
- Stereotactic Devices, Neuroendoscopy & Ultrasonic Aspirators
Market Report Data Types Included
- Unit Sales & Average Selling Prices (ASP)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Analysis & Market Shares
- Recent Mergers & Acquisitions
- Company Profiles & Product Portfolios
- Leading Competitors
U.S. Neurological Device Market Insights
Neuromodulation Leads Market Growth:
- Spinal cord stimulation (SCS), deep brain stimulation (DBS), and sacral nerve stimulation (SNS) are key segments.
- Closed-loop and AI-driven neuromodulation systems are improving personalized treatment efficacy.
- Growing applications in psychiatric disorders and pain management are expanding the market.
Neurovascular Thrombectomy Sees Rapid Expansion:
- Advancements in aspiration catheters and stent retrievers enhance procedural efficiency.
- Increased adoption of thrombectomy in stroke centers improves acute stroke care.
- AI and real-time imaging integration are optimizing clot retrieval outcomes.
U.S. Neurological Device Market Share Insights (2024)
1 Medtronic - Market Leader
- Dominant in neuromodulation, liquid embolics, intrathecal pumps, and stereotactic devices.
- Faces increasing competition in sacral nerve stimulation from Axonics.
- January 2025: Medtronic earns CE Mark approval for BrainSense Adaptive DBS and Electrode Identifier, advancing BCI technology for Parkinson’s care.
2 Stryker - Second-Largest Competitor
- Strong performance in neurovascular guidewires, detachable coils, and ultrasonic aspirators.
- January 2025: Stryker announces definitive agreement to acquire Inari Medical, strengthening its neurovascular portfolio.
- Focuses on minimally invasive neurovascular solutions for thrombectomy and aneurysm repair.
3 Abbott - Third-Largest Competitor
- Significant presence in neuromodulation with its Infinity™ DBS system and BurstDR™ spinal cord stimulation.
- January 2025: Abbott announces long-term efficacy of BurstDR™ SCS in chronic pain treatment, with 91% of patients preferring it over traditional methods.
- Introduced NeuroSphere™ Digital Health app for remote patient management.
Market Segmentation Summary
Cerebrospinal Fluid (CSF) Market - Further segmented into:
- CSF Shunts
- CSF External Drainage Systems
Detachable Coil Market - Further segmented into:
- Bare Platinum Coils
- Coated Coils
- Liquid Embolic Market
Neurovascular Catheter Market - Further segmented into:
- Over-the-Wire Microcatheters
- Flow-Directed Microcatheters
- Neurovascular Guiding Catheters
- Neurovascular Guidewire Market
Neurovascular Stent Market - Further segmented into:
- Traditional Neurovascular Stents
- Flow Diversion Stents
- Intrasaccular Stents
- Balloon Occlusion Device Market
Aneurysm Clip Market - Further segmented into:
- Titanium Clips
- Cobalt Alloy Clips
Neurovascular Thrombus Management Market - Further segmented into:
- Stent Retrievers
- Aspiration Catheters
- Aspiration Pump Canisters
Neuromodulation Device Market - Further segmented into:
- Spinal Cord Stimulation (SCS)
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Gastric Electric Stimulation (GES)
- Dorsal Root Ganglion Stimulation (DRG)
- Responsive Neurostimulation Devices
- Intrathecal Pump Market
Stereotactic Device Market - Further segmented into:
- Frame-based Stereotactic Devices
- Frameless Stereotactic Devices
Neuroendoscopy Market - Further segmented into:
- Rigid Endoscopes
- Flexible Endoscopes
- Videoscopes
- Single-Use Endoscopes
- Neuroendoscopic Hand Instruments
- Neuroendoscopy Disposables
Ultrasonic Aspirator Market - Further segmented into:
- Capital Equipment
- Disposable Probe Tips
- Disposable Tubing
- Handpieces
- Accessories
Research Scope Summary
- Regions Covered
- United States
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size & Growth Rates
- Procedure Numbers
- Unit Sales & ASP
- Market Shares & Forecasts through 2031
Qualitative Coverage
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls & Regulatory Developments
- Disruptive Technologies & Emerging Innovations
- Disease Overviews
Data Sources
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- Internal Database
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- LivaNova
- Acandis
- Medtronic
- Accuracy
- Terumo
- Adeor Medical
- Mizuho
- B Braun
- MRC
- Asahi Intecc
- Natus
- Avanos
- NeuroPace
- Axonics
- Nevro
- Balt
- NICO
- Biosense Webster
- Pentax Medical
- Bioventus
- Penumbra
- Boston Scientific
- Peter Lazic
- Brainlab
- Phenox
- Johnson & Johnson
- Philips
- Cirtec Medical
- Q’apel Medical
- Clarus Medical
- Rapid Medical
- Clearpoint
- Rogue
- Cook Medical
- Saluda Medical
- Dewimed
- Scientia Vascular
- Elekta
- Soering
- Embolx
- Sophysa
- Flowonix
- Stimwave
- Imperative Care
- Stryker
- InoMed
- Teleflex
- Integra LifeSciences
- Tenex Health
- IRRAS
- Varian
- Karl Storz
- Visionsense
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 322 |
Published | March 2024 |
Forecast Period | 2024 - 2031 |
Estimated Market Value ( USD | $ 7.6 Billion |
Forecasted Market Value ( USD | $ 10 Billion |
Compound Annual Growth Rate | 3.8% |
Regions Covered | United States |